Canopy Growth (TSX:WEED) Increases U.S. Investment: Is This Accretive to Growth?

How accretive to growth could Canopy Growth Corp’s (TSX:WEED)(NYSE:CGC) chosen U.S. strategy be?

| More on:

Canadian marijuana and hemp giant Canopy Growth Corp (TSX:WEED)(NYSE:CGC) announced a fresh hemp acquisition of a prominent United States hemp outfit on Thursday, and the company’s latest move may better position it for success in the nascent cannabis market south of the boarder.

What we know so far

The acquired company, AgriNextUSA is a hemp outfit co-founded by U.S. hemp pioneer Geoff Whaling who was a strong advocate for the newly legalized industry. The new acquisition had a strong vision to conquer the U.S. hemp market by operating at a higher level in the value chain — a view that is strongly supported by Canopy Growth.

The vision involves creating Hemp Industrial Parks “such as the one previously announced in New York State,” across America that will process the entire hemp crop “from root to tip” into “advanced materials, cosmetics, energy, fibre and textiles, food and protein production and the health and wellness” products like cannabidiol (CBD) oils while providing local farmers with regional destinations for their crop.

There seems to be a perfect strategic fit with this deal that will allow Canopy to serve several industry verticals while strongly positioning itself for a strong presence in the U.S. cannabis market in the future when it becomes federally legal to do so.

The latest acquisition’s total consideration is undisclosed, but it was on a cash basis. We’ll get more detail in the coming quarterly financial statements.

In summary, instead of buying up primary production assets like it did with cannabis in Canada, Canopy’s hemp business in the United States will be focused on manufacturing and new product development, leaving the farming of hemp to those who know it best, the American farmers.

A perfect market development strategy?

There’s cutthroat competition in the nascent U.S. hemp industry.

Unlike in Canada, where cannabis firms enjoyed some level of regulatory barriers to entry as Health Canada was a bit slow to issue new production and sales licenses to applicants, giving the early entrants some first mover advantages and wide room to knit their expansion strategies, the U.S. hemp space is a totally different playing field.

In the spirit of empowering American farmers, the new U.S. Farm Bill 2018 opened up the hemp industry to all, and there aren’t any significant barriers to market entry for those with access to the land, so a market development strategy that involves investing in primary agriculture is bound to face stiff competition from local farming communities.

Instead, investing in assets higher in the value chain is a more respectable entrepreneurial venture, and Canopy’s decision to build hemp industrial processing parks looks a better placed option in trying to conquer the new market.

How accretive?

Agriculture is a profitable business, but the value added and margins created by a company that does the processing, manufacturing and distribution may be much higher. Barley and sorghum farmers are not really as profitable as beer brewers in the alcoholic beverages market.

The new business plan allows Canopy to operate in several different industries including construction materials, synthetics and the legacy CBD cannabis oil line at a grand scale.

To think that Canopy will run multiple industrial parks in the United States stirs investor interest, especially if we deduce that the company is indeed building up some serious infrastructure that will make it a strong force to contend with in a new cannabis market when the legal framework finally allows.

Investor takeaway

Canopy Growth looks well positioned to rule the global cannabis market, and is well resourced to follow through on its expansion strategy after a $5 billion investment by Constellation Brands.

Management’s chosen strategic play in the United States looks a brilliant grant entrance by a global giant into a big, highly competitive new market and it positions the company for some significant success.

Should you invest $1,000 in Thomson Reuters right now?

Before you buy stock in Thomson Reuters, consider this:

The Motley Fool Stock Advisor Canada analyst team just identified what they believe are the Top Stocks for 2025 and Beyond for investors to buy now… and Thomson Reuters wasn’t one of them. The Top Stocks that made the cut could potentially produce monster returns in the coming years.

Consider MercadoLibre, which we first recommended on January 8, 2014 ... if you invested $1,000 in the “eBay of Latin America” at the time of our recommendation, you’d have $21,345.77!*

Stock Advisor Canada provides investors with an easy-to-follow blueprint for success, including guidance on building a portfolio, regular updates from analysts, and two new stock picks each month – one from Canada and one from the U.S. The Stock Advisor Canada service has outperformed the return of S&P/TSX Composite Index by 24 percentage points since 2013*.

See the Top Stocks * Returns as of 4/21/25

This article represents the opinion of the writer, who may disagree with the “official” recommendation position of a Motley Fool premium service or advisor. We’re Motley! Questioning an investing thesis — even one of our own — helps us all think critically about investing and make decisions that help us become smarter, happier, and richer, so we sometimes publish articles that may not be in line with recommendations, rankings or other content.

Fool contributor Brian Paradza has no position in any of the stocks mentioned.

Confidently Navigate Market Volatility: Claim Your Free Report!

Feeling uneasy about the ups and downs of the stock market lately? You’re not alone. At The Motley Fool Canada, we get it — and we’re here to help. We’ve crafted an essential guide designed to help you through these uncertain times: "5-Step Checklist: How to Prepare Your Portfolio for Volatility."

Don't miss out on this opportunity for peace of mind. Just click below to learn how to receive your complimentary report today!

Get Our Free Report Today

More on Cannabis Stocks

Cannabis business and marijuana industry concept as the shadow of a dollar sign on a group of leaves
Stocks for Beginners

Buy the Dip Before It’s Too Late: This Canadian Stock Won’t Stay Cheap Forever

Investors might think that cannabis stocks are out, but this one could be the top Canadian stock to consider.

Read more »

a person watches a downward arrow crash through the floor
Stocks for Beginners

Plummet Alert: Is This TSX Growth Stock a Bargain or a Falling Knife?

This growth stock was once a major winner, but can investors wait for more?

Read more »

Medicinal research is conducted on cannabis.
Cannabis Stocks

What to Know About Canadian Cannabis Stocks for 2025

Let's dive into two top Canadian cannabis stocks and where they may be headed from here (given the recent moves…

Read more »

Researcher works in hemp field
Cannabis Stocks

Aurora Cannabis Stock Is up 46% in 2025: Are Investors Going From 5 Years of Pain to a 2025 Gain?

Shares of Aurora Cannabis have staged a comeback in 2025, outpacing the broader markets comfortably. Is ACB stock a good…

Read more »

A plant grows from coins.
Stocks for Beginners

3 Growth Stocks That Could Skyrocket in 2025 and Beyond

It could be a big year for these sectors, and these growth stocks in particular throughout 2025.

Read more »

money goes up and down in balance
Tech Stocks

2 TSX Stocks to Buy and 2 to Avoid in the Looming Trade War

The looming U.S.-Canada trade war has changed the business environment. Here are some TSX stocks to buy and avoid in…

Read more »

space ship model takes off
Cannabis Stocks

2 Canadian Stocks With Strong Momentum for 2025

Celestica Inc. (TSX:CLS) stock and Dollarama (TSX:DOL) stock have sustained strong price growth momentum for a long time.  Here’s why…

Read more »

Worker tags plants at an industrial cannabis operation
Cannabis Stocks

Pot Stocks: Buy, Sell, or Hold in 2025?

Cannabis stocks remain a bit risky, but could long-term investors be in for more pain or far more profits?

Read more »